Groupe Francophone des Myelodysplasies

Amiens, Nîmes

OncologyPhase II

What changed

Study registered, no phase assigned: Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV

5mo agoTrial registeredJan 30, 2026Source filing (opens the source filing in a new tab)

Momentum

69no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Jun 6, 2024
ART Adherence · RECRUITING · sponsor: Florida International University · Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV
ClinicalTrials.gov · NCT06375135 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jun 22, 2021
MDS, AML · COMPLETED · sponsor: Groupe Francophone des Myelodysplasies · ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
ClinicalTrials.gov · NCT04857645 (opens the source filing in a new tab)
Trial
PHASE2 registered
May 1, 2021
Myelodysplastic Syndromes, Acute Myeloid Leukemia · COMPLETED · sponsor: Groupe Francophone des Myelodysplasies · BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
ClinicalTrials.gov · NCT04827719 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.93{"reasons":["name similarity 100%","shared principal investigator / founder"]}
Shared principal investigator or founder links the trial record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
new_entity links the trial record at 0.22{"reasons":["no candidate cleared the review threshold"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV
5mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV
5mo agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
May 2025Trial completedSource (opens the source filing in a new tab)
Phase II trial registered: ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
May 2025Trial completedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

NA registered

PHASE2 registered

PHASE2 registered